Literature DB >> 6406026

Pseudomonas aeruginosa exoproducts as pulmonary virulence factors.

H A Cash, D C Straus, J A Bass.   

Abstract

An experimental animal model of chronic pseudomonas pneumonia was used to document the production of potential virulence factors by Pseudomonas aeruginosa during the infection. The production of exotoxin A, proteolytic enzymes, and the serotype-specific lipopolysaccharide and slime-layer antigens during the infection was examined by solid-phase radioimmunoassay of serum from infected rats and by indirect immunofluorescence tests of their lung tissue. Rats inoculated intratracheally with purified bacterial exoproducts, delivered alone or in combination, developed pulmonary histopathology similar to that induced by the experimental infection. The results indicate that these exoproducts are produced during the course of the pulmonary infection and suggest that they are involved in the observed lung pathology.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6406026     DOI: 10.1139/m83-072

Source DB:  PubMed          Journal:  Can J Microbiol        ISSN: 0008-4166            Impact factor:   3.226


  8 in total

1.  Pyocyanin and 1-hydroxyphenazine produced by Pseudomonas aeruginosa inhibit the beating of human respiratory cilia in vitro.

Authors:  R Wilson; T Pitt; G Taylor; D Watson; J MacDermot; D Sykes; D Roberts; P Cole
Journal:  J Clin Invest       Date:  1987-01       Impact factor: 14.808

2.  Four epitopes of Pseudomonas aeruginosa elastase defined by monoclonal antibodies.

Authors:  J Lagacé; M Fréchette
Journal:  Infect Immun       Date:  1991-02       Impact factor: 3.441

3.  Importance of a lipopolysaccharide-containing extracellular toxic complex in infections produced by Klebsiella pneumoniae.

Authors:  D C Straus; D L Atkisson; C W Garner
Journal:  Infect Immun       Date:  1985-12       Impact factor: 3.441

4.  Cytotoxicity of Pseudomonas aeruginosa internal lectin PA-I to respiratory epithelial cells in primary culture.

Authors:  O Bajolet-Laudinat; S Girod-de Bentzmann; J M Tournier; C Madoulet; M C Plotkowski; C Chippaux; E Puchelle
Journal:  Infect Immun       Date:  1994-10       Impact factor: 3.441

5.  Contribution of specific Pseudomonas aeruginosa virulence factors to pathogenesis of pneumonia in a neonatal mouse model of infection.

Authors:  H B Tang; E DiMango; R Bryan; M Gambello; B H Iglewski; J B Goldberg; A Prince
Journal:  Infect Immun       Date:  1996-01       Impact factor: 3.441

6.  Effect of chemotactins released by Staphylococcus aureus and Pseudomonas aeruginosa on the murine respiratory tract.

Authors:  D O Sordelli; M C Cerquetti; A Morris Hooke; J A Bellanti
Journal:  Infect Immun       Date:  1985-08       Impact factor: 3.441

7.  Effect of bacterial products on human ciliary function in vitro.

Authors:  R Wilson; D Roberts; P Cole
Journal:  Thorax       Date:  1985-02       Impact factor: 9.139

8.  Reaction of antibody in sera from cystic fibrosis patients with non-toxic forms of Pseudomonas aeruginosa exotoxin A.

Authors:  K W Klinger; C W Shuster; J Klinger
Journal:  Eur J Clin Microbiol       Date:  1985-04       Impact factor: 5.103

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.